Endpoints News 9. Apr. 2026 Roche dips into DACs with existing partner C4 Therapeutics for $20M upfront
Endpoints News 21. März 2026 Roche, Nvidia’s 'AI Factory'; Industry looks to soften MFN impact; Structure’s oral GLP-1 data; and more
Endpoints News 14. März 2026 Roche’s breast cancer failure; BioNTech co-founders to depart; Eli Lilly’s quest to stay on top; and more
Endpoints News 2. März 2026 Roche gets third pivotal win with MS drug, but liver signal could be a problem
Endpoints News 9. Feb. 2026 #ACTRIMS26: Roche’s MS drug fenebrutinib beats Ocrevus, cutting risk of disability progression by 12%
Endpoints News 8. Jan. 2026 Ollin’s drug clears retinal disease better than Roche’s Vabysmo in Phase 1b trial
Endpoints News 8. Jan. 2026 Charles Fuchs leaves Roche to steer ADC pipeline at Tubulis shortly after $401M Series C